期刊文献+

颈动脉粥样硬化的中医药认识及研究进展 被引量:11

The TCM Cognition and Research Progress of Carotid Atherosclerosis
下载PDF
导出
摘要 动脉粥样硬化(AS)是心脑血管疾病发生的重要危险因素与病理基础,而颈动脉粥样硬化斑块(CAS)更是预测、判断全身重要动脉病变情况的关键因素。因此对颈动脉粥样硬化斑块的干预和防治具有重要的临床意义。目前现代医学对颈动脉粥样硬化斑块的治疗主要是通过他汀类等药物调脂稳定斑块以及抗血小板聚集药物的治疗。但在部分人群中,这些药物的使用,存在诱发转氨酶升高、出血等用药安全性问题。因此中医药对颈动脉粥样硬化斑块的防治越来越受到重视。文章通过对近年来颈动脉粥样硬化的中医药研究的相关文献进行分析、总结,从中医对颈动脉粥样斑块的病名认识、病因病机认识、其与体质的关系、辨证分型、辨证治疗等方面对其研究进展进行论述。 Atherosclerosis(AS) is an important risk factor and pathological basis of cardiovascular and cerebrovascular diseases. Carotid atherosclerosis(CAS) is a key factor to judging aorta lesion. It is important to prevention and cure of CAS. Now it used drugs to treat CAS which can stabilize plaques as statins and antiplatelet medication in western medicine.But there are safety problems in drugs use such as to elevate SGPT level and bleeding in part of population. So the prevention and cure of TCM on ACS is receiving more and more attention. It is to discuss the TCM research progress of CAS on name, etiology, pathogenesis, syndrome diferentiation and treatment by analyzing and summarizing the related literature in the article.
作者 林嘉文 薛金贵 赵国定 陈军 LIN Jiawen;XUE Jin'gui;ZHAO Guoding;CHEN Jun(Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China;Department of Cardiology, Shanghai Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China;Department of TCM, Shanghai Huangpu District Central Hospital, Shanghai 200002, China;Department of Cardiology, Shanghai Yangpu District Hospital of TCM, Shanghai 200090, China)
出处 《中国卫生标准管理》 2018年第9期109-111,共3页 China Health Standard Management
基金 上海市杨浦区医学重点学科项目(YP16ZB08)
关键词 颈动脉粥样硬化 中医药 综述 carotid atherosclerosis TCM literature review
  • 相关文献

参考文献20

二级参考文献127

共引文献176

同被引文献155

引证文献11

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部